0001209191-21-050944.txt : 20210811 0001209191-21-050944.hdr.sgml : 20210811 20210811171737 ACCESSION NUMBER: 0001209191-21-050944 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210809 FILED AS OF DATE: 20210811 DATE AS OF CHANGE: 20210811 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tate Simon CENTRAL INDEX KEY: 0001867441 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40708 FILM NUMBER: 211164600 MAIL ADDRESS: STREET 1: C/O ELIEM THERAPEUTICS, INC. STREET 2: 23515 NE NOVELTY HILL RD, STE B221 #125 CITY: REDMOND STATE: WA ZIP: 98053 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eliem Therapeutics, Inc. CENTRAL INDEX KEY: 0001768446 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 832273741 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 23515 NE NOVELTY HILL RD., SUITE B221 #1 CITY: REDMOND STATE: WA ZIP: 98077 BUSINESS PHONE: 16502240857 MAIL ADDRESS: STREET 1: 23515 NE NOVELTY HILL RD., SUITE B221 #1 CITY: REDMOND STATE: WA ZIP: 98077 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-08-09 0 0001768446 Eliem Therapeutics, Inc. ELYM 0001867441 Tate Simon C/O ELIEM THERAPEUTICS, INC. 23515 NE NOVELTY HILL RD, STE. B221 #125 REDMOND WA 98053 1 0 0 0 Stock Option (Right to Buy) 12.50 2021-08-09 4 A 0 20000 0.00 A 2031-08-08 Common Stock 20000 20000 D For so long as the Reporting Person continuously provides services to the Issuer, this option will vest with respect to the shares as follows: 1/36th of the shares will vest on each monthly anniversary of August 1, 2021. /s/ Alan Hambelton, Attorney-in-Fact 2021-08-11